Enanta Pharma (ENTA) Tops Q1 EPS by 39c

Enanta Pharma (NASDAQ: ENTA) reported Q1 EPS of ($0.42), $0.39 better than the analyst estimate of ($0.81). Revenue for the quarter came in at $18.6 million versus the consensus estimate of $16.05 million.

For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• Cellebrite (CLBT) PT Lowered to $15 at DA Davidson Following Q2 Miss
• StablecoinX reports Q2 2026 results with $34.2M net loss